21 /100
LOW RISK
Score updated May 28, 2026

VYGR — Voyager Therapeutics, Inc. Dilution Risk Tracker

Track VYGR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track VYGR — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for VYGR.
🔔 Track VYGR — Get forecast alerts →

💹 Market Data

Market Cap$235.64M
Shares Outstanding60.42M
Float44.22M
Cash$141.48M
Debt$34.57M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 10.8% shares (2025Q4 vs prior)
123 institutional holders · 34.48M shares
#1 BlackRock, Inc. 5.62M shares
#2 EcoR1 Capital, LLC 4.00M shares
#3 ARMISTICE CAPITAL, LLC 4.00M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest3.66M
Days to Cover8.6
% of Float8.3%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2015
xbrl XBRL WARRANT Dec 31, 2015
4 INSIDER TRANSACTION Feb 26, 2026
4 INSIDER TRANSACTION Feb 26, 2026
4 INSIDER TRANSACTION Feb 26, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track VYGR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking VYGR — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for VYGR
📊 VYGR FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 VYGR Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.